跳至主要内容
临床试验/DRKS00020382
DRKS00020382招募中不适用

Treatment exit options for non-infectious uveitis - TOF

niversitätsklinikum Bonn0 个研究点目标入组 4,000 人开始时间: 2020年2月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
4,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Male or female subjects who are =18 years of age, on the day of signing informed consent
  • - Ability to consent
  • - Non-infectious intermediate, posterior or panuveitis or retinal vasculitis

排除标准

  • - Missing or unwilling to consent
  • - Any prior therapy with DMARDs
  • - Intravitreal therapy with dexamethasone, VEGF-Inhibitors, triamcinolone or sirolimus in the last 6 months
  • - Intravitreal therapy with fluocinolone acetonide or methotrexate in the last 36 months
  • - Intraocular surgery within the last 6 months
  • - Severe opacities of cornea, lens or vitreous that preclude assessment of inflammatory activity of the posterior pole
  • - Conceivable inability to attend regularly at participating centre

研究者

发起方
niversitätsklinikum Bonn

相似试验

Treatment exit options for non-infectious uveitis | 临床试验